β-glucan from Saccharomyces cerevisiae as a blood platelet antioxidant

References

• Archibald MN, Israels SJ. Platelets and anti-platelets therapy. J Pharmacol Sci 2003; 93: 381–396
   PubMed Web of Science ®Google Scholar
• Denese S, Fiocchi C. Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease. Crit Rev Immunol 2005; 25: 103–121
   PubMed Web of Science ®Google Scholar
• Jane E, Freedman MD. Molecular regulation of platelet-dependent thrombosis. Circulation 2005; 112: 2725–2734
   PubMed Web of Science ®Google Scholar
• Lundblad RL, White GC. The interaction of thrombin with blood platelets. Platelets 2005; 16: 373–382
   PubMed Web of Science ®Google Scholar
• Spinelli SL, Brien JJ, Bancos S, Lehmann GM, Springer DL, Blumberg N, Francis CW, Taubman MD. The PPAR-Platelet Connection: Modulators of inflammation and potential cardiovascular effects. PPAR Res 2008; 1: 1–16
   Google Scholar
• Gawaz M, Langer H, May E. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378–3384
   PubMed Web of Science ®Google Scholar
• Olas B, Wachowicz B. Role of reactive nitrogen species in blood platelet functions. Platelets 2007; 18: 555–565
   PubMed Web of Science ®Google Scholar
• Krotz F, Sohn HY, Pohl U. Reactive oxygen species, players in the platelet game. Arterioscler Thromb Vasc Biol 2004; 24: 1988–1996
   PubMed Web of Science ®Google Scholar
• Wachowicz B, Olas B, Zbikowska HM, Buczyński A. Generation of reactive oxygen species in blond platelets. Platelets 2002; 13: 175–182
   PubMed Web of Science ®Google Scholar
• John B, Hansch GM. Oxygen radical generation in human platelets: Dependence of 12-lipoxygenase activity and on the glutathione cycle. Int Arch Allergy Immunol 1990; 93: 73–79
   Web of Science ®Google Scholar
• Olas B, Wachowicz B, Nowak P. Oxidative/nitrative modification of blood platelet proteins induced by thrombin in vitro. Thromb Res 2009; 123: 758–762
   PubMed Web of Science ®Google Scholar
• Bloodsworth A, Valerine B, Freeman BA. Nitric oxide regulation of free radical- and enzyme-mediated lipid and lipoprotein oxidation. Arterioscler Thromb Vas Biol 2000; 20: 1707–1715
   PubMed Web of Science ®Google Scholar
• Danese S, Motte Cd Cde L, Fiocchi MD. Platelets in inflammatory bowel disease: Clinical, pathogenic, and therapeutic implications. Am J Gastroenterol 2004; 99: 938–945
   PubMed Web of Science ®Google Scholar
• Matthias HF, Klinger WJ. Role of blood platelets in infection and inflammation. J Inter Cyt Res 2004; 9: 913–922
   Google Scholar
• Pitchford SC. Novel uses for anti-platelet agents as anti-inflammatory drugs. Br J Pharmacol 2007; 152: 987–1002
   PubMed Web of Science ®Google Scholar
• Saluk–Juszczak J. Znaczenie lipopolisachrydu bakteryjnego w procesie aktywacji płytek krwi. Post Biol Kom 2007; 34: 159–172
   Google Scholar
• Matthias HF. Platelets and inflammation. Anat Embryol 1997; 196: 1–11
   PubMedGoogle Scholar
• Rukhsana A, Edwin R, Kim M, Crow AR, Bang KWA. Platelet Toll-like receptor expression modulates lipopolysaccharyde- induced thrombocytopenia and tumor necrosis factor–α production in vivo. Blood 2006; 107: 637–641
   PubMed Web of Science ®Google Scholar
• Xiao-Feng Y, Ying Y, Wang H. Vascular inflammation and atherogenesis are sctivated via receptors for PAMPs and suppressed by regulatory T cells. Drug Disco Today 2008; 5: 125–142
   Google Scholar
• Gawaz M, Langer H. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378–3384
   PubMed Web of Science ®Google Scholar
• Garry G, Susan J, Janet AM. Plant polyphenols in cancer and heart disease: Implications as nutritional antioxidants. Nutrition 2000; 13: 79–106
   Web of Science ®Google Scholar
• Kogan G, Stasko A, Bauerova K, Palonka M. Antioxidant properties of yeast (1→3)-β-D-glucan studied by electron paramagnetic resonance spectroscopy and its activity in the adjuvant arthritis. Carbohyd Polym 2005; 61: 18–28
   Web of Science ®Google Scholar
• Akramienė D, Anatolijus K, Didžiapetrienė J. Effects of β-glucans on the immune system. Medicina (Kaunas) 2007; 43: 597–606
   PubMed Web of Science ®Google Scholar
• Olas B, Wachowicz B. Resveratrol and vitamin C as antioxidants in blood platelets. Thromb Res 2002; 106: 143–148
   PubMed Web of Science ®Google Scholar
• Olas B, Saluk-Juszczak J, Wachowicz B. D-glucaro 1,4-lactone and resveratrol as antioxidants in blond platelets. Cell Biol Toxicol 2008; 24: 189–199
   PubMed Web of Science ®Google Scholar
• Pryor W, Cueto R, Koppenol WH, Ngu-Achwemlein M, Squadrito GL, Uppu PL, Uppu RM. A practical method for preparing peroxynitrite solutions of low ionic strength and free of hydrogen peroxide. Free Rad Biol Med 1995; 18: 75–83
   PubMed Web of Science ®Google Scholar
• Wachowicz B, Kustron J. Effect of cisplatin on lipid peroxidation in pig blood platelets. Cytobios 1992; 70: 41–47
   PubMedGoogle Scholar
• Walkowiak B, Michalak E, Koziolkiewicz W, Cierniewski CS. Rapid photometric metod for estimation of platelet count in blood plasama or platelet supension. Thromb Res 1985; 56: 763–766
   Google Scholar
• Walkowiak B. Adenine nucleotides in thrombocytes of birds. Cell Biochem Function 1984; 2: 167–170
   PubMed Web of Science ®Google Scholar
• Buss H, Chan TP, Sluis KB, Winterbourn CC, Domigan NM. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 1997; 23: 361–366
   PubMed Web of Science ®Google Scholar
• Levine RL, Garland D, Oliver CN, Amici A, Climent I. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464–476
   PubMed Web of Science ®Google Scholar
• Khan J, Brennan DM, Bradley N, Gao B, Brukdorfer R, Jacobs M. 3-Nitrotyrosine in the proteins of human plasma determined by an Elisa method. J Biochem 1998; 330: 795–801
   Google Scholar
• Olas B, Nowak P, Kołodziejczyk J, Wachowicz B. The effects of antioxidants on peroxynitrite-induced changes in platelet proteins. Thromb Res 2004; 113: 399–406
   PubMed Web of Science ®Google Scholar
• Sadula J, Kogan G, Kacurkova M, Machova E. Microbial (1→3)-β-D-glucans, their preparation, physico-chemical characterization and immunomodulatory activity. Carbohydrate Polymers 1999; 38: 247–253
   Web of Science ®Google Scholar
• Gordon D, Brown G. Fungal β-glucans and mammalian immunity. Immunity 2003; 1: 311–315
   Google Scholar
• Laroche C, Michaud P. New developments and prospective applications for β (1,3) glucans. Recent Pat Biotechnol 2007; 1: 59–73
   PubMedGoogle Scholar
• Yan J, Allendorf DJ, Brandley B. Yeast whole glucan particle (WGP) β-glucan in conjunction with antitumour monoclonal antibodies to treat cancer. Expert Opinion Biol Ther 2005; 5: 691–702
   PubMed Web of Science ®Google Scholar
• Hunter KW, Jr, Gault RA, Berner MD. Preparation of microparticulate beta-glucan from Saccharomyces cerevisiae for use in immune potentiation. Lett Appl Microbiol 2002; 35: 267–271
   PubMed Web of Science ®Google Scholar
• Vetvicka V, Thornton BP, Ross GD. Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J Clin Invest 1996; 98: 50–61
   PubMed Web of Science ®Google Scholar
• Patchen ML, MacVittie TJ. Stimulated hemopoiesis and enhanced survival following glucan treatment in sublethally and lethally irradiated mice. Int J Immunopharmacol 1985; 7: 923–932
   PubMed Web of Science ®Google Scholar
• Ostroff GR, Ross GD, Jo Dockter Ross T. Patent application title: Methods of using beta glucan as a radioprotective agent. CONCORD, MA USA. IPC8 Class: AA61K31716FI; USPC Class: 514 54.
   Google Scholar
• Volman JJ, Ramakers JD, Plat J. Dietary modulation of immune function by β-glucans. Physiol Behavior 2008; 94: 276–284
   PubMed Web of Science ®Google Scholar
• Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung NK, Ross GD. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol 2004; 173: 797–806
   PubMed Web of Science ®Google Scholar
• Cramer DE, Allendorf DJ, Baran JT, Hansen R, Marroquin J, Li B, Ratajczak J, Ratajczak MZ, Yan J. beta-Glucan enhances complement-mediated hematopoietic recovery after bone marrow injury. Blood 2006; 107: 835–840
   PubMed Web of Science ®Google Scholar
• Allendorf DJ, Ross GD, Ostrol GR. Oral WGP beta-glucan treatment accelerates myeloid recovery and survival after radiation exposure. Science & Technology for Reducing Biological Threats & Countering Terrorism 2003; 104–111
   Google Scholar
• Elzey BD, Tian J, Jansen RJ, Swanson AK. Platelets mediated modulation of adapted immunity. A communication link between innate and adaptive immune compartments. Immunity 2003; 19: 9–19
   PubMed Web of Science ®Google Scholar
• Kim GY, Choi GS, Lee SH, Park YM. Acidic polysaccharide isolated from Phellinus linteus enhances through the upregulation of nitric oxide and tumor necrosis factor-alpha from peritoneal macrophages. J Ethnophara 2004; 95: 69–76
   PubMed Web of Science ®Google Scholar
• Shebuski JR, Kilgore SK. Role of inflammatory mediators in thrombogenesis. J Pharmacol Exp Ther 2002; 3: 729–35
   Google Scholar
• Ari JF, Francisco AB. Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections. Clin Microbiol Rev 2009; 22: 396–414
   PubMed Web of Science ®Google Scholar
• Ferroni P, Basili S, Martini F, Vieri M. Soluble P-selectin as marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J Thromb Haemost 2000; 3: 531–540
   Google Scholar
• Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin J. Increased circulating platelet-leukocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Hematol 2001; 115: 566–601
   Web of Science ®Google Scholar
• Fagerstam JP, Whiss PA, Strom M, Andersson A. Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease. Inflamm Res 2000; 49: 466–472
   PubMed Web of Science ®Google Scholar
• Ross R. Atheroschlerosis: An inflammatory disease. N Engl J Med 1999; 340: 115–126
   PubMed Web of Science ®Google Scholar
• Saluk-Juszczak, Krolewska K, Wachowicz B. Response of blood platelets to β-glucan from Saccharomyces cerevisiae. Platelets 2010;21:37–43.
   Google Scholar
• Cheung P, Salas E, Schulz R, Radomski M. Nitric oxide and platelet function: Implications for neonatology. Semin Perinatol 2003; 21: 409–417
   Google Scholar
• Lufrano M, Balazy M. Interactions of peroxynitrite and other nitrating substances with human platelets: The role of glutatione and peroxynitrite permeability. Biochem Pharmacol 2003; 65: 515–523
   PubMed Web of Science ®Google Scholar
• Mazzulli JR, Hodara R, Summer L, Ischiropoulos H. Oxidative stress and protein deposition diseases. Protein Rev 2007; 24: 123–133
   Google Scholar
• Reiter CD, Teng RJ, Beckman JS. Reaction of superoxide and nitric with peroxynitrite. J Biol Chem 2000; 275: 32460–32466
   PubMed Web of Science ®Google Scholar
• Ischiropoulos H, Mehdi AM. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett 1995; 364: 279–282
   PubMed Web of Science ®Google Scholar
• Tsiapali E, Whaley S, Kalbfleisch J, Ensley HE. Glukan exhibit weak antioxidant activity, but stimulate macrophage free radical activity. Free Rad Biol Med 2001; 30: 393–402
   PubMed Web of Science ®Google Scholar
• Babineau TJ, Hackford A, Kenler A, Bristrian B. A phase II imulticenter double-blind randomized placebo controlled study of three dosage of an immunomodulator (PPG-glucan) in high-risk surgical patients. Arch Surg 1994; 129: 1204–1210
   PubMedGoogle Scholar
• Karen LD, Martin E, Murad F. Novel effects of nitric oxide. Anuu Rev Pharmacol Toxicol 2001; 41: 203–236
   PubMed Web of Science ®Google Scholar
• Butterfield AD, Tanea T, Perluigi M, Raffaella R, Jeffrey N. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: Implications for the role of nitration in the progression of Alzheimer's disease. Brain Res 2007; 1148: 243–248
   PubMed Web of Science ®Google Scholar
• Mirshafiey A, Mohsenzadegan M. Antioxidant therapy in multiple sclerosis. Immunopharm Immunotoxic 2009; 31: 13–29
   PubMed Web of Science ®Google Scholar